Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Zinc finger protein 614 pseudogene" (LOC643381, ENSG00000254939) is a human genomic sequence related to the zinc finger protein 614 family but is classified as a pseudogene, meaning it does not encode a functional protein product. Pseudogenes arise through gene duplication or retrotransposition events and typically accumulate mutations that prevent them from being transcribed or translated into functional proteins. As such, this pseudogene has no demonstrated biological function, is not considered a drug or therapeutic target, and is not used in clinical practice as a biomarker or for patient selection. Zinc finger proteins in general are a large family of transcription factors characterized by the presence of zinc finger motifs, which enable DNA binding and regulatory activity[2][4]. However, pseudogenes—such as "zinc finger protein 614 pseudogene"—do not produce functional proteins and typically have no direct molecular interactions, biological functions, or disease associations that are therapeutically actionable. This entry is not a functional drug target, receptor, transcription factor, nor any other active biomolecule. The "is_incorrect" flag is set to true because this entry is a pseudogene, which does not fulfill the typical criteria for a molecular or therapeutic target. If you intended to refer to a functional zinc finger protein instead, such as "zinc finger protein 684" (ZNF684) or another member of the family, more specific information and different structured outputs would apply[1]. "Zinc finger protein 614 pseudogene" (LOC643381, ENSG00000254939) is a non-functional genetic relic, not a recognized therapeutic target, and holds no canonical abbreviation, clinical, or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 614 pseudogene.